Mid-term outcomes of first metatarsophalangeal arthroplasty using the Primus FGT double-stemmed silicone implants

Stefano Fieschi, Mo Saffarini, Luigi Manzi, Arrigo Fieschi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Silicone implants for first metatarsophalangeal (MTP-1) arthroplasty are regaining popularity, though most studies have long inclusion periods, or short follow-up. The authors aimed to report mid-term outcomes of a cohort that received a third-generation MTP-1 implant at minimum follow-up of 5 years. Methods The authors evaluated 70 MTP-1 arthroplasties performed in 64 patients using the Primus™ Flexible Great Toe implant. The indications were hallux rigidus of grade II (10%) and grade III (87.1%) or revision surgery (2.9%). Results All patients completed clinical and radiographic assessments at 83.5 months (range, 62–114). There were no revisions or reoperations and the AOFAS-HMI score was 88.9 ± 9.1 (median, 90; range, 67–100). Metatarsalgia was ‘absent’ in 47.1%, ‘mild’ in 41.1%, ‘moderate’ in 7.1% and ‘severe’ in 1.4%. Conclusion This study reported excellent mid-term clinical outcomes and survival rates of a third generation MTP-1 arthroplasty design and confirmed findings of recent studies regarding efficacy of silicone double-stemmed implants. Level of evidence Level IV case series.

Original languageEnglish
Pages (from-to)142-147
Number of pages6
JournalFoot and Ankle Surgery
Volume23
Issue number3
DOIs
Publication statusPublished - Sep 1 2017
Externally publishedYes

Fingerprint

Silicones
Arthroplasty
Reoperation
Hallux Rigidus
Metatarsalgia
Hallux
Survival Rate

Keywords

  • Hallux rigidus
  • Hallux valgus
  • Metatarsophalangeal arthroplasty
  • MTP arthroplasty
  • Silicone implants

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Mid-term outcomes of first metatarsophalangeal arthroplasty using the Primus FGT double-stemmed silicone implants. / Fieschi, Stefano; Saffarini, Mo; Manzi, Luigi; Fieschi, Arrigo.

In: Foot and Ankle Surgery, Vol. 23, No. 3, 01.09.2017, p. 142-147.

Research output: Contribution to journalArticle

Fieschi, Stefano ; Saffarini, Mo ; Manzi, Luigi ; Fieschi, Arrigo. / Mid-term outcomes of first metatarsophalangeal arthroplasty using the Primus FGT double-stemmed silicone implants. In: Foot and Ankle Surgery. 2017 ; Vol. 23, No. 3. pp. 142-147.
@article{688763c6e6394ea3983ab1a51a781a11,
title = "Mid-term outcomes of first metatarsophalangeal arthroplasty using the Primus FGT double-stemmed silicone implants",
abstract = "Background Silicone implants for first metatarsophalangeal (MTP-1) arthroplasty are regaining popularity, though most studies have long inclusion periods, or short follow-up. The authors aimed to report mid-term outcomes of a cohort that received a third-generation MTP-1 implant at minimum follow-up of 5 years. Methods The authors evaluated 70 MTP-1 arthroplasties performed in 64 patients using the Primus™ Flexible Great Toe implant. The indications were hallux rigidus of grade II (10{\%}) and grade III (87.1{\%}) or revision surgery (2.9{\%}). Results All patients completed clinical and radiographic assessments at 83.5 months (range, 62–114). There were no revisions or reoperations and the AOFAS-HMI score was 88.9 ± 9.1 (median, 90; range, 67–100). Metatarsalgia was ‘absent’ in 47.1{\%}, ‘mild’ in 41.1{\%}, ‘moderate’ in 7.1{\%} and ‘severe’ in 1.4{\%}. Conclusion This study reported excellent mid-term clinical outcomes and survival rates of a third generation MTP-1 arthroplasty design and confirmed findings of recent studies regarding efficacy of silicone double-stemmed implants. Level of evidence Level IV case series.",
keywords = "Hallux rigidus, Hallux valgus, Metatarsophalangeal arthroplasty, MTP arthroplasty, Silicone implants",
author = "Stefano Fieschi and Mo Saffarini and Luigi Manzi and Arrigo Fieschi",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.fas.2016.11.009",
language = "English",
volume = "23",
pages = "142--147",
journal = "Foot and Ankle Surgery",
issn = "1268-7731",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Mid-term outcomes of first metatarsophalangeal arthroplasty using the Primus FGT double-stemmed silicone implants

AU - Fieschi, Stefano

AU - Saffarini, Mo

AU - Manzi, Luigi

AU - Fieschi, Arrigo

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Background Silicone implants for first metatarsophalangeal (MTP-1) arthroplasty are regaining popularity, though most studies have long inclusion periods, or short follow-up. The authors aimed to report mid-term outcomes of a cohort that received a third-generation MTP-1 implant at minimum follow-up of 5 years. Methods The authors evaluated 70 MTP-1 arthroplasties performed in 64 patients using the Primus™ Flexible Great Toe implant. The indications were hallux rigidus of grade II (10%) and grade III (87.1%) or revision surgery (2.9%). Results All patients completed clinical and radiographic assessments at 83.5 months (range, 62–114). There were no revisions or reoperations and the AOFAS-HMI score was 88.9 ± 9.1 (median, 90; range, 67–100). Metatarsalgia was ‘absent’ in 47.1%, ‘mild’ in 41.1%, ‘moderate’ in 7.1% and ‘severe’ in 1.4%. Conclusion This study reported excellent mid-term clinical outcomes and survival rates of a third generation MTP-1 arthroplasty design and confirmed findings of recent studies regarding efficacy of silicone double-stemmed implants. Level of evidence Level IV case series.

AB - Background Silicone implants for first metatarsophalangeal (MTP-1) arthroplasty are regaining popularity, though most studies have long inclusion periods, or short follow-up. The authors aimed to report mid-term outcomes of a cohort that received a third-generation MTP-1 implant at minimum follow-up of 5 years. Methods The authors evaluated 70 MTP-1 arthroplasties performed in 64 patients using the Primus™ Flexible Great Toe implant. The indications were hallux rigidus of grade II (10%) and grade III (87.1%) or revision surgery (2.9%). Results All patients completed clinical and radiographic assessments at 83.5 months (range, 62–114). There were no revisions or reoperations and the AOFAS-HMI score was 88.9 ± 9.1 (median, 90; range, 67–100). Metatarsalgia was ‘absent’ in 47.1%, ‘mild’ in 41.1%, ‘moderate’ in 7.1% and ‘severe’ in 1.4%. Conclusion This study reported excellent mid-term clinical outcomes and survival rates of a third generation MTP-1 arthroplasty design and confirmed findings of recent studies regarding efficacy of silicone double-stemmed implants. Level of evidence Level IV case series.

KW - Hallux rigidus

KW - Hallux valgus

KW - Metatarsophalangeal arthroplasty

KW - MTP arthroplasty

KW - Silicone implants

UR - http://www.scopus.com/inward/record.url?scp=85028559064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028559064&partnerID=8YFLogxK

U2 - 10.1016/j.fas.2016.11.009

DO - 10.1016/j.fas.2016.11.009

M3 - Article

AN - SCOPUS:85028559064

VL - 23

SP - 142

EP - 147

JO - Foot and Ankle Surgery

JF - Foot and Ankle Surgery

SN - 1268-7731

IS - 3

ER -